Nature Portfolio aims to enhance the reproducibility of published research through a structured reporting form. This form ensures consistency and transparency in reporting. Key points include: 1. **Statistics**: All statistical analyses must be clearly documented, including sample size, measurement methods, statistical tests, and assumptions. The full description of statistical parameters, effect sizes, and P values is required. 2. **Software and Code**: Information on the availability of computer code is mandatory. 3. **Data**: A data availability statement must be provided, detailing access codes, identifiers, and any restrictions on data use. 4. **Human Participants and Data**: Policies for studies involving human participants, their data, or biological material are outlined, including ethical oversight and reporting on sex, gender, and race. 5. **Field-Specific Reporting**: Different sections are provided for life sciences, behavioral & social sciences, and ecological, evolutionary & environmental sciences, each with specific disclosure requirements. 6. **Study Design**: Disclosures for sample size, data exclusions, replication, randomization, and blinding are required for all studies. 7. **Materials & Experimental Systems**: Authors must indicate if specific materials, systems, or methods are relevant to their study. 8. **Methods**: Detailed information on methods, including antibodies, cell lines, animals, and clinical data, is required. 9. **Antibodies, Animals, and Clinical Data**: Specific policies for animal research, clinical studies, and dual-use research of concern are outlined. 10. **Experiments of Concern**: Information on potentially harmful experiments is required. 11. **Plants**: Policies for seed stocks, novel plant genotypes, and authentication are provided. 12. **ChIP-seq**: Data deposition and methodology details are required. 13. **Flow Cytometry**: Specific requirements for plot labels, scales, and numerical values are outlined. 14. **Magnetic Resonance Imaging (MRI)**: Experimental design, imaging parameters, and statistical modeling are detailed. 15. **Behavioral Performance Measures**: Details on behavioral performance measures and imaging types are provided. This comprehensive reporting form ensures that all relevant information is included in published manuscripts, enhancing the transparency and reproducibility of research.Nature Portfolio aims to enhance the reproducibility of published research through a structured reporting form. This form ensures consistency and transparency in reporting. Key points include: 1. **Statistics**: All statistical analyses must be clearly documented, including sample size, measurement methods, statistical tests, and assumptions. The full description of statistical parameters, effect sizes, and P values is required. 2. **Software and Code**: Information on the availability of computer code is mandatory. 3. **Data**: A data availability statement must be provided, detailing access codes, identifiers, and any restrictions on data use. 4. **Human Participants and Data**: Policies for studies involving human participants, their data, or biological material are outlined, including ethical oversight and reporting on sex, gender, and race. 5. **Field-Specific Reporting**: Different sections are provided for life sciences, behavioral & social sciences, and ecological, evolutionary & environmental sciences, each with specific disclosure requirements. 6. **Study Design**: Disclosures for sample size, data exclusions, replication, randomization, and blinding are required for all studies. 7. **Materials & Experimental Systems**: Authors must indicate if specific materials, systems, or methods are relevant to their study. 8. **Methods**: Detailed information on methods, including antibodies, cell lines, animals, and clinical data, is required. 9. **Antibodies, Animals, and Clinical Data**: Specific policies for animal research, clinical studies, and dual-use research of concern are outlined. 10. **Experiments of Concern**: Information on potentially harmful experiments is required. 11. **Plants**: Policies for seed stocks, novel plant genotypes, and authentication are provided. 12. **ChIP-seq**: Data deposition and methodology details are required. 13. **Flow Cytometry**: Specific requirements for plot labels, scales, and numerical values are outlined. 14. **Magnetic Resonance Imaging (MRI)**: Experimental design, imaging parameters, and statistical modeling are detailed. 15. **Behavioral Performance Measures**: Details on behavioral performance measures and imaging types are provided. This comprehensive reporting form ensures that all relevant information is included in published manuscripts, enhancing the transparency and reproducibility of research.